The purpose is to evaluate the safety and efficacy of MESNA in the short-term treatment of persistent pain following surgery of the back.

• Conditions: Failed Back Syndrome; MedDRA version: 14.0Level: SOCClassification code 10028395Term: Musculoskeletal and connective tissue disordersSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2011-004258-24-IT
• Lead Sponsor: IVERSITA' CAMPUS BIOMEDICO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-11-29
• Last Update Posted: 3 April 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

presence of FBSS
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

the presence of infectious processes in place, or impairment of the coagulation cascade to the risk of local complications, and patients are pregnant (and therefore the patients of childbearing age will be made to sign an informed consent to undergo the procedure in which attests not pregnant, as is commonly done for X-rays).

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified